NCT00108134View on ClinicalTrials.gov

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Basal Cell Carcinoma
Interventions
DRUG

PEP005

Trial Locations (9)

2010

Southderm Pty Ltd, Sydney

2217

St George Dermatology & Skin Cancer Centre, Sydney

3053

Skin and Cancer Foundation, Melbourne

4000

Siller Medical, Brisbane

4152

Belmont Specialist Centre, Brisbane

4217

The Skin Centre, Gold Coast

6008

St John of God Dermatology, Subiaco

6160

Freemantle Dermatology, Freemantle

Private Dermaology Clinic, Fremantle

Sponsors

Lead Sponsor

Peplin
All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00108134 - Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | Biotech Hunter | Biotech Hunter